PROBS Stock Overview
Researches, manufactures, and sells probiotics for dietary supplements and food companies in North America, South America, Europe, Sweden, the Middle East, Africa, Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Probi AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 304.00 |
| 52 Week High | SEK 304.00 |
| 52 Week Low | SEK 283.00 |
| Beta | 0.76 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -0.98% |
| 5 Year Change | -30.12% |
| Change since IPO | 88.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| PROBS | GB Biotechs | GB Market | |
|---|---|---|---|
| 7D | 0% | 1.5% | 2.2% |
| 1Y | n/a | -17.9% | 8.8% |
Return vs Industry: Insufficient data to determine how PROBS performed against the UK Biotechs industry.
Return vs Market: Insufficient data to determine how PROBS performed against the UK Market.
Price Volatility
| PROBS volatility | |
|---|---|
| PROBS Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 9.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.2% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: PROBS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PROBS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 166 | Tom Ronnlund | www.probi.com |
Probi AB (publ) researches, develops, manufactures, markets, and sells probiotics for health, pharmaceutical, and food companies. The company conducts research primarily in the fields of gastrointestinal health, digestive health, immune health, bone health, and iron absorption, as well as children’s, women’s, and senior health. It provides dietary supplement, and food and beverage products in the form of capsules, tablets and spheres, chewable tablets, powder, fruit drinks, shots, carbonated beverages, and recovery drinks.
Probi AB (publ) Fundamentals Summary
| PROBS fundamental statistics | |
|---|---|
| Market cap | SEK 2.83b |
| Earnings (TTM) | SEK 78.71m |
| Revenue (TTM) | SEK 658.13m |
36.0x
P/E Ratio4.3x
P/S RatioIs PROBS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PROBS income statement (TTM) | |
|---|---|
| Revenue | SEK 658.13m |
| Cost of Revenue | SEK 365.39m |
| Gross Profit | SEK 292.74m |
| Other Expenses | SEK 214.03m |
| Earnings | SEK 78.71m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Oct 21, 2022
| Earnings per share (EPS) | 6.91 |
| Gross Margin | 44.48% |
| Net Profit Margin | 11.96% |
| Debt/Equity Ratio | 0% |
How did PROBS perform over the long term?
See historical performance and comparison